Helen has over 30 years of post-graduate experience of Pharmaceutical Development in a Contract Research environment. Initially as a pathologist and then a Study Director, she has been a Senior Consulting Toxicologist at Labcorp (previously Covance, Envigo and Huntingdon Life Sciences) since 2005, as has been at the forefront of scientific and technical method development within the organisation throughout that time, as a Toxicologist and as a UK Home Office Licence Holder for in vivo work. She has written or peer reviewed over 1000 study reports, utilising all standard non-clinical toxicology species and all dose routes, concentrating on pharmaceuticals and biopharmaceuticals.
Her extensive skillset combined into the Inhalation Toxicologist role in early 2020, at the start of the COVID pandemic. Since then, she has peer reviewed over 100 Inhalation study reports, designed over 50 inhalation programmes, and presented several posters and presentations within the Inhalation Industry.